IBRX Articles and Guides
TickerPosts guides and articles tagged IBRX. Plain-English, calm, and written for everyday investors. 1 post.
ImmunityBio (IBRX) Stock News: FDA Expands Anktiva Approval to All BCG-Unresponsive Bladder Cancer
The FDA expanded Anktiva’s approval to cover BCG-unresponsive non-muscle-invasive bladder cancer with papillary-only tumors, the first approval to include that group, which the company says is about 85% of patients.
· 1 min read